Scopa James Paul - Insider Non-Derivative Transactions at Aligos Therapeutics, Inc. (ALGS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Oct 25, 2023, Scopa James Paul's relationship to Aligos Therapeutics, Inc. (ALGS) is Director, and currently has 183,083 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ALGS insiders.
Data Source: SEC.
Scopa James Paul - Insider Non-Derivative Transactions at ALGS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Oct 26, 2023 | Acquisition -- (Common Stock) | 183083 | 0.76 | 183083 |